BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27816053)

  • 1. Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens.
    Karatas OF; Suer I; Yuceturk B; Yilmaz M; Oz B; Guven G; Cansiz H; Creighton CJ; Ittmann M; Ozen M
    BMC Cancer; 2016 Nov; 16(1):853. PubMed ID: 27816053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.
    Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L
    Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells.
    Karatas OF; Suer I; Yuceturk B; Yilmaz M; Hajiyev Y; Creighton CJ; Ittmann M; Ozen M
    Tumour Biol; 2016 Mar; 37(3):4183-92. PubMed ID: 26490990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
    Guo R; Wu Q; Liu F; Wang Y
    Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
    Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
    Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinogenicity study of CD133(+)CD44(+) laryngeal cancer stem cells and identification of related microRNAs].
    Li Y; Zhou XH; Chen ZH; Dai LL; Cui CX; Wu HL; Wei QY; Fan KM; Xu YL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 54(7):529-533. PubMed ID: 31315361
    [No Abstract]   [Full Text] [Related]  

  • 7. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
    Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
    Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
    Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells.
    Yang L; Yan Z; Wang Y; Ma W; Li C
    Cell Biochem Funct; 2016 Aug; 34(6):404-13. PubMed ID: 27338789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.
    Hongdan L; Feng L
    Biochem Biophys Res Commun; 2018 Feb; 496(2):302-308. PubMed ID: 29307822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-135a-induced formation of CD133+ subpopulation with cancer stem cell properties in cervical cancer.
    Leung CON; Deng W; Ye TM; Ngan HYS; Tsao SW; Cheung ANY; Ziru N; Yuen DCK; Pang RTK; Yeung WSB
    Carcinogenesis; 2020 Nov; 41(11):1592-1604. PubMed ID: 32415843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-598 inhibits the growth and maintenance of gastric cancer stem-like cells by down-regulating RRS1.
    Ma Y; Yan F; Wei W; Deng J; Li L; Liu L; Sun J
    Cell Cycle; 2019 Oct; 18(20):2757-2769. PubMed ID: 31438772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
    Zekri AN; El-Sisi ER; Youssef ASE; Kamel MM; Nassar A; Ahmed OS; El Kassas M; Barakat AB; Abd El-Motaleb AI; Bahnassy AA
    PLoS One; 2018; 13(3):e0193709. PubMed ID: 29534065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells.
    Fomeshi MR; Ebrahimi M; Mowla SJ; Khosravani P; Firouzi J; Khayatzadeh H
    Cell Mol Biol Lett; 2015 Sep; 20(3):448-65. PubMed ID: 26208390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
    Yu X; Mi L; Dong J; Zou J
    BMC Cancer; 2017 Nov; 17(1):716. PubMed ID: 29110645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
    Wu Q; Guo R; Lin M; Zhou B; Wang Y
    Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line.
    Nam EJ; Lee M; Yim GW; Kim JH; Kim S; Kim SW; Kim YT
    BMC Med Genomics; 2012 May; 5():18. PubMed ID: 22643117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2.
    Wu N; Xiao L; Zhao X; Zhao J; Wang J; Wang F; Cao S; Lin X
    FEBS Lett; 2012 Nov; 586(21):3831-9. PubMed ID: 22999819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Metformin on the Proliferation, Apoptosis and CD133 mRNA Expression of Colon Cancer Stem Cells by Upregulation of miR 342-3p.
    Zhang Y; Chen R; Deng L; Shuai Z; Chen M
    Drug Des Devel Ther; 2021; 15():4633-4647. PubMed ID: 34815662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.